Your browser doesn't support javascript.
loading
Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
Naim, Mohd Javed; Alam, Ozair; Alam, Md Jahangir; Shaquiquzzaman, Mohammad; Alam, Md Mumtaz; Naidu, Vegi Ganga Modi.
Affiliation
  • Naim MJ; Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
  • Alam O; Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
  • Alam MJ; Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
  • Shaquiquzzaman M; Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
  • Alam MM; Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
  • Naidu VGM; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hyderabad, India.
Arch Pharm (Weinheim) ; 351(3-4): e1700223, 2018 Apr.
Article in En | MEDLINE | ID: mdl-29400412

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Thiazolidinediones / PPAR gamma / Diabetes Mellitus, Experimental / Molecular Docking Simulation / Hypoglycemic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Arch Pharm (Weinheim) Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Thiazolidinediones / PPAR gamma / Diabetes Mellitus, Experimental / Molecular Docking Simulation / Hypoglycemic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Arch Pharm (Weinheim) Year: 2018 Document type: Article Affiliation country: Country of publication: